JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma
Clinical trial NCT06045585 · UNKNOWN
Trial details
- NCT number
- NCT06045585
- Sponsor
- Guangdong Second Provincial General Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-18
- Primary completion
- 2025-08-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.